Pipoxizine
Pipoxizine (INN) is a first-generation antihistamine as well as serotonin antagonist of the diphenylmethylpiperazine group related to hydroxyzine.[1][2] It was investigated as a bronchodilator but was never marketed.[1][3][4]
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C24H31NO3 |
Molar mass | 381.508 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
References
- C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 1619–. ISBN 978-0-412-46630-4.
- World Health Organization (1988). International Nonproprietary Names (INN) for Pharmaceutical Substances. W.H.O.
- Brunner A, Gartmann J, Studler H. "Pipoxizine, a New Bronchodilator". Lung. 154 (2): 143.
- Neukirch F, Korobaeff M, Verdier F, Timsit G, Fay M, Drutel P (1978). "[Effect of a histamine aerosol in 20 subjects with histamine hyperreactivity. Application to a study of the protective properties of pipoxizine]". Rev Inst Hyg Mines (Hasselt) (in French). 33 (4): 191–5. PMID 45187.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.